Related Experiment Video

Updated: May 26, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

[Disease progression and systolic dysfunction in patients with hypertrophic cardiomyopathy: genetic basis,

Giulia Poggesi1, Cecilia Ferrantini, Eleonora Servettini

  • 1Centro di Riferimento per le cardiomopatie, Azienda Ospedaliera Universitaria Careggi, Firenze.

Giornale Italiano Di Cardiologia (2006)
|December 14, 2011
PubMed

Insights

End-stage hypertrophic cardiomyopathy (HCM) involves heart failure from left ventricular remodeling. Early identification of patients at risk is crucial for potential intervention and improved outcomes.

Area of Science:

  • Cardiology
  • Heart Failure Research
  • Hypertrophic Cardiomyopathy

Background:

  • Hypertrophic cardiomyopathy (HCM) can progress to end-stage (ES) heart failure, characterized by left ventricular remodeling and systo-diastolic dysfunction.
  • The mechanisms driving this progression, particularly from a hyperdynamic state to ES-HCM, are not fully understood.
  • Current understanding of HCM progression, management, and prevention strategies remains incomplete.

Purpose of the Study:

  • To highlight the importance of understanding HCM progression to end-stage heart failure.
  • To emphasize the need for early identification of patients at risk of ES-HCM.
  • To discuss potential therapeutic strategies that may interfere with disease evolution.

Main Methods:

  • Review of recent evidence on HCM progression.
  • Analysis of mechanisms underlying left ventricular remodeling in HCM.
  • Identification of early-stage indicators for ES-HCM risk.

Main Results:

  • End-stage (ES) HCM is a severe complication of hypertrophic cardiomyopathy (HCM).
  • Early stages of HCM, even with preserved systolic function, may precede significant remodeling and dysfunction.
  • Identifying at-risk patients early is key to potentially altering the disease's natural history.

Conclusions:

  • Early identification of patients at risk for end-stage (ES) hypertrophic cardiomyopathy (HCM) is critical.
  • Intervention during early stages, when systolic function may be preserved, offers the best chance to prevent progression to heart failure.
  • Further research is needed to elucidate mechanisms and develop effective management and prevention strategies for ES-HCM.

More Related Videos

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...